軟組織同種移植片の世界市場：成長、将来の見通し、競合分析（2022年～2030年）

世界の軟組織同種移植片の市場規模は、2022年～2030年の予測期間において、7.5％のCAGRで成長すると予測されています。また、業界の2021年の売上高は約42億米ドルでした。

市場の拡大は、事故による負傷者の増加や高齢者人口の増加などが主な要因として挙げられます。また軟組織同種移植片の普及には、技術の進歩が寄与しています。無菌組織同種移植片のニーズは、人口の高齢化、陸上競技における軟組織同種移植片の需要増、組織バンクの数の増加、整形外科手術の数の増加など、様々な要因によって高まっています。企業の多くは、軟組織同種移植片の導入準備を進めており、認知度の向上により、軟組織同種移植片市場は世界的に拡大することが予想されます。

当レポートでは、世界の軟組織同種移植片市場について調査分析し、市場概要、市場の促進要因・抑制要因、課題や機会、セグメント別・地域別の市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

• レポートの説明
  • レポートの目的
  • 対象者
  • 主な製品
• 市場セグメンテーション
• 調査手法
  • フェーズI：2次調査
  • フェーズII：1次調査
  • フェーズIII：専門家による審査
  • 前提条件
  • 採用されたアプローチ

第2章 エグゼクティブサマリー

• 市場スナップショット
• 世界の軟組織同種移植片市場：製品別（2021年）
• 世界の軟組織同種移植片市場：用途別（2021年）
• 世界の軟組織同種移植片市場：エンドユーザー別（2021年）
• 世界の軟組織同種移植片市場：地域別（2021年）
• COVID-19の影響
• 魅力的な投資提案：地域別（2021年）
• 競合分析
  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要な業界戦略

第3章 軟組織同種移植片市場：事業の見通しと市場力学

• イントロダクション
• 市場価値（2020年～2030年）
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
• PESTEL分析

第4章 軟組織同種移植片市場：製品別（2020年～2030年）

• 市場概要
• 成長と収益分析：2021年/2030年
• 市場セグメンテーション
  • 軟骨同種移植片
  • 腱同種移植片
  • 半月板同種移植片
  • 歯の同種移植片
  • コラーゲン同種移植片
  • 羊膜同種移植片

第5章 軟組織同種移植片市場：用途別（2020年～2030年）

• 市場概要
• 成長と収益分析：2021年対2030年
• 市場セグメンテーション
  • 整形外科
  • 歯科
  • 創傷ケア
  • その他

第6章 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）

• 市場概要
• 成長と収益分析：2021年/2030年
• 市場セグメンテーション
  • 病院
  • 整形外科クリニック
  • 歯科クリニック
  • 外来手術センター
  • 美容センター

第7章 北米の軟組織同種移植片市場（2020年～2030年）

• 市場概要
• 軟組織同種移植片市場：製品別（2020年～2030年）
• 軟組織同種移植片市場：用途別（2020年～2030年）
• 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）
• 軟組織同種移植片市場：地域別（2020年～2030年）
  • 北米

第8章 英国・欧州連合の軟組織同種移植片市場（2020年～2030年）

• 市場概要
• 軟組織同種移植片市場：製品別（2020年～2030年）
• 軟組織同種移植片市場：用途別（2020年～2030年）
• 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）
• 軟組織同種移植片市場：地域別（2020年～2030年）
  • 英国・欧州連合

第9章 アジア太平洋地域の軟組織同種移植片市場（2020年～2030年）

• 市場概要
• 軟組織同種移植片市場：製品別（2020年～2030年）
• 軟組織同種移植片市場：用途別（2020年～2030年）
• 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）
• 軟組織同種移植片市場：地域別（2020年～2030年）
  • アジア太平洋地域

第10章 ラテンアメリカの軟組織同種移植片市場（2020年～2030年）

• 市場概要
• 軟組織同種移植片市場：製品別（2020年～2030年）
• 軟組織同種移植片市場：用途別（2020年～2030年）
• 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）
• 軟組織同種移植片市場：地域別（2020年～2030年）
  • ラテンアメリカ

第11章 中東・アフリカの軟組織同種移植片市場（2020年～2030年）

• 市場概要
• 軟組織同種移植片市場：製品別（2020年～2030年）
• 軟組織同種移植片市場：用途別（2020年～2030年）
• 軟組織同種移植片市場：エンドユーザー別（2020年～2030年）
• 軟組織同種移植片市場：地域別（2020年～2030年）
  • 中東・アフリカ

第12章 企業プロファイル

• Abbvie Inc. (Allergan)
• Conmed Corporation
• Becton Dickinson and Company
• Smith & Nephew (Osiris Therapeutics Inc.)
• Integra LifeSciences Corporation
• Stryker Corporation
• Zimmer Biomet
• Arthrex Inc.
• Direct Biologics
• その他

List of Tables

• TABLE 1 Global Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 2 Global Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 3 Global Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 4 Global Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 5 Global Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 6 Global Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 7 Global Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 8 Global Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)
• TABLE 9 North America Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 10 North America Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 11 North America Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 12 North America Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 13 North America Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 14 North America Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 15 North America Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 16 North America Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)
• TABLE 17 UK and European Union Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 18 UK and European Union Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 19 UK and European Union Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 20 UK and European Union Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 21 UK and European Union Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 22 UK and European Union Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 23 UK and European Union Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 24 UK and European Union Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)
• TABLE 25 Asia Pacific Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 26 Asia Pacific Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 27 Asia Pacific Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 28 Asia Pacific Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 29 Asia Pacific Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 30 Asia Pacific Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 31 Asia Pacific Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 32 Asia Pacific Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)
• TABLE 33 Latin America Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 34 Latin America Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 35 Latin America Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 36 Latin America Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 37 Latin America Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 38 Latin America Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 39 Latin America Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 40 Latin America Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)
• TABLE 41 Middle East and Africa Soft Tissue Allografts Market By Product, 2020-2030, USD (Million)
• TABLE 42 Middle East and Africa Soft Tissue Allografts Market By Cartilage Allografts, 2020-2030, USD (Million)
• TABLE 43 Middle East and Africa Soft Tissue Allografts Market By Tendon Allografts, 2020-2030, USD (Million)
• TABLE 44 Middle East and Africa Soft Tissue Allografts Market By Dental Allografts, 2020-2030, USD (Million)
• TABLE 45 Middle East and Africa Soft Tissue Allografts Market By Application, 2020-2030, USD (Million)
• TABLE 46 Middle East and Africa Soft Tissue Allografts Market By Orthopedic, 2020-2030, USD (Million)
• TABLE 47 Middle East and Africa Soft Tissue Allografts Market By Dentistry, 2020-2030, USD (Million)
• TABLE 48 Middle East and Africa Soft Tissue Allografts Market By End-user, 2020-2030, USD (Million)

List of Figures

• FIG. 1 Global Soft Tissue Allografts Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Soft Tissue Allografts Market: Quality Assurance
• FIG. 5 Global Soft Tissue Allografts Market, By Product, 2021
• FIG. 6 Global Soft Tissue Allografts Market, By Application, 2021
• FIG. 7 Global Soft Tissue Allografts Market, By End-user, 2021
• FIG. 8 Global Soft Tissue Allografts Market, By Geography, 2021
• FIG. 9 Global Soft Tissue Allografts Market, By Product, 2021 Vs 2030, %
• FIG. 10 Global Soft Tissue Allografts Market, By Application, 2021 Vs 2030, %
• FIG. 11 Global Soft Tissue Allografts Market, By End-user, 2021 Vs 2030, %
• FIG. 12 U.S. Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 13 Canada Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 14 Rest of North America Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 15 UK Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 16 Germany Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 17 Spain Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 18 Italy Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 19 France Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 20 Rest of Europe Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 21 China Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 22 Japan Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 23 India Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 24 Australia Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 25 South Korea Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 26 Rest of Asia Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 27 Brazil Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 28 Mexico Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 29 Rest of Latin America Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 30 GCC Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 31 Africa Soft Tissue Allografts Market (US$ Million), 2020 - 2030
• FIG. 32 Rest of Middle East and Africa Soft Tissue Allografts Market (US$ Million), 2020 - 2030

The global market for soft tissue allografts is expected to grow at a CAGR of 7.5% during the forecast period of 2022 to 2030. In addition, the industry had a revenue of approximately US $4.2 billion in 2021. The expansion of the market can mostly be ascribed to the rising number of people who have been injured in accidents and the growing elderly population. According to projections made by the World Health Organization (WHO), the total number of individuals aged 60 and older across the globe would reach 1.4 billion by the year 2030. The advancement of technology has contributed to the rise in the popularity of soft tissue allografts. The need for sterile tissue allografts is being driven by a number of factors, including an ageing population, an increase in the demand for soft tissue allografts in athletics, growth in the number of tissue banks, and an increase in the number of orthopaedic surgical procedures. The majority of corporations are making preparations to introduce items that are soft tissue allografts. It is anticipated that an increase in awareness will assist in the expansion of the market for soft tissue allografts worldwide. Significant strides have been made in the education of patients, which can be attributed in part to the expansion of internet access and the proliferation of social media platforms. It is anticipated that an increase in consumers' understanding of products and methods will be beneficial to the global market for soft tissue allografts. In addition, it is anticipated that underlying healthcare trends, the rise in the importance of sports, and the rise in the population of elderly people would drive expansion in the global market.

Market To Be Driven by Clinical Applications in Medical Procedures and Sports Injuries

Athletes competing in modern athletics, field events, and a variety of other contact sports, such as American football, are required to take part in hard training sessions that are frequently more taxing than the sport itself. However, excessive training creates exhaustion in the muscles and bones and frequently leads to injuries. High-intensity training regimens are closely associated with enhanced athletic performance; however, excessive training does not improve athletic performance. Accidents, impacts, bad training habits, a lack of conditioning, inappropriate equipment, inadequate warm-up and stretching, and other factors can all contribute to the development of sports injuries. Injuries among young people are on the rise as a direct result of their participation in a single sport for the entire year. The American Academy of Paediatrics estimates that around 30 million children and teenagers in the United States participate in organised sports each year, which results in more than 3.5 million injuries. One-third of all injuries sustained by children occur as a result of participation in sports.

The Global Market Is Expected to Expand as A Result of The Growing Number of Orthodontic and Dental Cases Associated with Ageing

People of advanced age have a greater risk of sustaining damage to their soft tissues. People naturally become slower as they age, and have less energy, and less power as they progress through the years. Because of this, individuals are more likely to sustain injuries. People aged 65 and older have a higher risk of dying from falls than any other cause. It is by far the most typical cause for older patients to check themselves into the emergency room. The elderly population has a higher prevalence of tooth loss, which can be brought on by either disease or trauma. The use of dental implants as a means of providing support for the replacement of missing teeth has a lengthy and intricate history. In the most recent few years, there has been a growth in research on dental implant designs, materials, and methods. It is anticipated that it will go up in the not-too-distant future as a result of the expansion of the market for dental implants and the growing interest in cosmetic dentistry. It is anticipated that this will drive the size of the soft tissue allografts market in the not-too-distant future.

Increasing Prevalence of Osteoarthritis

Osteoarthritis has a significant effect on the individual patient, causing them to suffer from pain and incapacity; as a result, the market is anticipated to experience growth in the not-too-distant future due to the growing prevalence of this condition. For instance, according to the statistics compiled by the National Health Service of the United Kingdom in the year 2020, tennis elbow was a prevalent condition that affected approximately 1% to 3% of the population, which corresponds to approximately 4 to 7 cases per 1,000 people each and every year. The market for soft tissues is beginning to establish its footing because of technological advancement. There are a lot of businesses on the market today that have the goal of launching items that will contribute to the expansion of the market; however, the expansion of consumers' knowledge and awareness of these products will also play a significant role. The general public now has a higher degree of knowledge, which can be attributed in large part to the expansion of internet access and the simplification of access to social media. Growing familiarity with both products and production methods will prove beneficial to the market for soft tissue over the course of time.

Other Causes Boosting the Need for Soft Tissue Allografts

An Increase in the Number of Victims of Trauma - The World Health Organization estimates that about 1.3 million people lose their lives too soon as a direct result of being involved in a traffic collision every single year. Between 20 and 50 million people in the world are incapacitated as a direct result of non-fatal injuries, and the majority of these people are unable to work.

An increasing number of people are suffering from musculoskeletal conditions, which affect around 1.71 billion people all over the world.

Increasing Incomes Per Person According to the World Bank, the yearly global per capita revenue climbed by 4.8% in 2021, which is a significant improvement from the 1.5% gain seen in 2019.

Dental Allograft Dominated the Market in 2021

The allograft market can be segmented into Dental Allograft, Tendon Allograft, Cartilage Allograft, Meniscus Allograft, and Other Allografts, depending on the type of product that is being sold. Dental allograft dominated the market in 2021. In the majority of cases, a dental bone transplant is performed after extraction in order to preserve the edentulous area in preparation for the insertion of an implant. Following tooth extraction, ridge augmentation and socket preservation are procedures that are carried out in order to reduce the amount of significant bone loss and anomalies. By employing a bone transplant, ridge augmentation has the potential to restore both the height and width of lost bone, while also preventing additional bone loss. The process of filling an extraction socket with bone or a bone substitute during a treatment known as "socket preservation" can improve the likelihood of success for subsequent dental surgeries such as dental implants, dentures, or bridges. When upper posterior teeth are taken, the floor of the maxillary sinus may become loose and fall out, leaving behind only a little quantity of bone.

Cartilage Allograft to Lead the Growth During the Forecast Period

Patients who are missing cartilage or osteochondral tissue have a number of therapy options available to them, one of which is an osteochondral allograft, or OCA, transplantation. For instance, one study titled "Osteochondral Allograft Transplant for Focal Cartilage Defects of the Femoral Condyles: Clinically Significant Outcomes, Failures, and Survival at a Minimum 5-Year Follow-up" found that osteochondral transplant demonstrates significant clinical improvement and durability at mid-to-long-term follow-up, with 5 and 10-year survival rates of 86.2% and 81.8%, respectively. The study was conducted as a result, and the enhanced effectiveness of OCA will be the driving force behind the segmental expansion.

In orthopaedic surgery operations such as joint repair and other similar procedures, cartilage allografts are an essential component. In the treatment of chondral and osteochondral lesions, particularly those that occur in the knee, cartilage graft transplantation is a procedure that is utilised regularly. These procedures have the potential to improve one's quality of life and decrease symptoms for those who suffer from a condition that affects the cartilage found within the joints. Osteochondral allograft (OCA) is a procedure that involves the transplantation of fully developed or mature hyaline (joint) cartilage that contains living cartilage cells (known as "chondrocytes"). These cartilage cells are able to survive the transplant and continue to support the production of the cartilage matrix indefinitely after the procedure.

Hospital Remained the Dominant End-Use Segment

Hospitals account for the largest share of the market in 2021. Soft tissue allograft is utilised by specialists in clinics for the purpose of shoulder repair, spinal fusion, knee and ankle joint reconstruction, meniscal replacement, reconstruction as a result of cancer or damage, ridge augmentation in dental procedures, and urological operations. Repair of the anterior cruciate ligament (also known as ACL) is one of the most common orthopaedic surgeries, with more than 200,000 procedures carried out each year at a rate ranging from 30 to 78 per 100,000 people. ACL reconstruction techniques have evolved over the course of time, transitioning from open surgeries that restricted postoperative weight-bearing and range of motion to arthroscopically assisted single-incision approaches that enabled patients to immediately resume full weight-bearing and range of motion. In a similar vein, there has been a fundamental shift in the selection of grafts.

North America Remains as the Global Leader

In 2021, the market for soft tissue allografts was led by North America. Because of the presence of important players and the region's high rate of technology adoption, it is expected that the market in this region will develop at the highest CAGR during the forecast period of 2022 to 2030. Additionally, the prevalence of diabetic foot ulcers, improvements in diabetes healthcare awareness initiatives, and an increase in the number of surgical procedures are all contributing factors that are expanding the market share of soft tissue allografts in North America. It is anticipated that market expansion will be driven by the introduction of new products in the region. For instance, the Food and Drug Administration of the United States (FDA) received marketing authorisation for an anterior cruciate ligament (ACL) implant in December 2020. This implant was designed to serve as an alternative to ACL reconstruction in the treatment of ACL rupture. In the treatment of ACL ruptures, this device can be used to reconstruct the ligament using an allograft, an autograft, or just sutures alone.

In addition, the report entitled "Canadian Institute for Health Information 2020" found that the number of Canadians who have undergone joint replacement surgery has increased over the course of the previous five years, with 138,000 operations being carried out annually. In the 2019-2020 medical year, there were approximately 63,000 hip replacements and 75,000 knee replacements carried out in Canada. As a result, the increasing number of hip and knee replacements performed in Canada is anticipated to drive the market for soft tissue allografts because these products are utilised in surgical procedures. Therefore, the growing burden of diseases is producing the huge potential for market players, and these market players are focusing their efforts on research and development activities in order to provide new and trustworthy products into the market, which is driving the expansion of the market. For instance, in February 2020, Integra LifeSciences Holding Corporation introduced AmnioExcel Plus Placental Allograft Membrane as their most recent wound care offering to enhance soft tissue recovery. This particular product was developed by the company. As a consequence of this, thanks to the aforementioned factors, it is anticipated that the market would have a high growth rate throughout the course of the forecast year.

Product Launches Remain as the Key Strategy to Combat Intensifying Competition

The market for soft tissue allografts is moderately competitive, and a large number of international players are currently active within the market. Abbvie Inc. (Allergan), Conmed Corporation, Becton Dickinson and Company, Smith & Nephew (Osiris Therapeutics Inc.), Integra LifeSciences Corporation, Stryker Corporation, Zimmer Biomet, Arthrex Inc., and Direct Biologics are some of the companies that compete in this industry. Additionally, new product launches by these players are contributing to an increase in demand for the aforementioned products. There are a large number of key players in the global soft tissue allografts market, which contributes to the market's fragmentation. The most important strategies that the dominant players have implemented thus far include expanding their product lines and engaging in mergers and acquisitions.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Soft Tissue Allografts market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Soft Tissue Allografts market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Cartilage Allografts

Hyaline Cartilage

Elastic Cartilage

Fibro Cartilage

Tendon Allografts

Achilles Tendon

Tibialis

Patellar Tendon

Hamstring

Meniscus Allografts

Dental Allografts

Free Gingival Graft

Connective Tissue Graft

Pedicle Graft

Collagen Allografts

Amniotic Allografts

Application

Orthopedic

Sports Medicine

Spine Surgeries

General Orthopedic

Reconstruction

Dentistry

Dental Sensitivity

Aesthetics

Wound Care

Others

End-user

Hospitals

Orthopedic Clinics

Dental Clinics

Ambulatory Surgical Centers

Aesthetic Centers

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Soft Tissue Allografts market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Soft Tissue Allografts market?

Which is the largest regional market for Soft Tissue Allografts market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Soft Tissue Allografts market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Soft Tissue Allografts market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Soft Tissue Allografts Market
• 2.2. Global Soft Tissue Allografts Market, By Product, 2021 (US$ Million)
• 2.3. Global Soft Tissue Allografts Market, By Application, 2021 (US$ Million)
• 2.4. Global Soft Tissue Allografts Market, By End-user, 2021 (US$ Million)
• 2.5. Global Soft Tissue Allografts Market, By Geography, 2021 (US$ Million)
• 2.6. Impact of Covid 19
• 2.7. Attractive Investment Proposition by Geography, 2021
• 2.8. Competitive Analysis
  • 2.8.1. Market Positioning of Key Soft Tissue Allografts Market Vendors
  • 2.8.2. Strategies Adopted by Soft Tissue Allografts Market Vendors
  • 2.8.3. Key Industry Strategies

3. Soft Tissue Allografts Market: Business Outlook & Market Dynamics

• 3.1. Introduction
• 3.2. Global Soft Tissue Allografts Market Value, 2020 - 2030, (US$ Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers
  • 3.3.2. Market Restraints
  • 3.3.3. Key Challenges
  • 3.3.4. Key Opportunities
• 3.4. Impact Analysis of Drivers and Restraints
• 3.5. See-Saw Analysis
• 3.6. Porter's Five Force Model
  • 3.6.1. Supplier Power
  • 3.6.2. Buyer Power
  • 3.6.3. Threat Of Substitutes
  • 3.6.4. Threat Of New Entrants
  • 3.6.5. Competitive Rivalry
• 3.7. PESTEL Analysis
  • 3.7.1. Political Landscape
  • 3.7.2. Economic Landscape
  • 3.7.3. Technology Landscape
  • 3.7.4. Legal Landscape
  • 3.7.5. Social Landscape

4. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)

• 4.1. Market Overview
• 4.2. Growth & Revenue Analysis: 2021 Versus 2030
• 4.3. Market Segmentation
  • 4.3.1. Cartilage Allografts
    • 4.3.1.1. Hyaline Cartilage
    • 4.3.1.2. Elastic Cartilage
    • 4.3.1.3. Fibro Cartilage
  • 4.3.2. Tendon Allografts
    • 4.3.2.1. Achilles Tendon
    • 4.3.2.2. Tibialis
    • 4.3.2.3. Patellar Tendon
    • 4.3.2.4. Hamstring
  • 4.3.3. Meniscus Allografts
  • 4.3.4. Dental Allografts
    • 4.3.4.1. Free Gingival Graft
    • 4.3.4.2. Connective Tissue Graft
    • 4.3.4.3. Pedicle Graft
  • 4.3.5. Collagen Allografts
  • 4.3.6. Amniotic Allografts

5. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2021 Versus 2030
• 5.3. Market Segmentation
  • 5.3.1. Orthopedic
    • 5.3.1.1. Sports Medicine
    • 5.3.1.2. Spine Surgeries
    • 5.3.1.3. General Orthopedic
    • 5.3.1.4. Reconstruction
  • 5.3.2. Dentistry
    • 5.3.2.1. Dental Sensitivity
    • 5.3.2.2. Aesthetics
  • 5.3.3. Wound Care
  • 5.3.4. Others

6. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2021 Versus 2030
• 6.3. Market Segmentation
  • 6.3.1. Hospitals
  • 6.3.2. Orthopedic Clinics
  • 6.3.3. Dental Clinics
  • 6.3.4. Ambulatory Surgical Centers
  • 6.3.5. Aesthetic Centers

7. North America Soft Tissue Allografts Market, 2020-2030, USD (Million)

• 7.1. Market Overview
• 7.2. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)
• 7.3. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)
• 7.4. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)
• 7.5.Soft Tissue Allografts Market: By Region, 2020-2030, USD (Million)
  • 7.5.1.North America
    • 7.5.1.1. U.S.
    • 7.5.1.2. Canada
    • 7.5.1.3. Rest of North America

8. UK and European Union Soft Tissue Allografts Market, 2020-2030, USD (Million)

• 8.1. Market Overview
• 8.2. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)
• 8.3. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)
• 8.4. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)
• 8.5.Soft Tissue Allografts Market: By Region, 2020-2030, USD (Million)
  • 8.5.1.UK and European Union
    • 8.5.1.1. UK
    • 8.5.1.2. Germany
    • 8.5.1.3. Spain
    • 8.5.1.4. Italy
    • 8.5.1.5. France
    • 8.5.1.6. Rest of Europe

9. Asia Pacific Soft Tissue Allografts Market, 2020-2030, USD (Million)

• 9.1. Market Overview
• 9.2. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)
• 9.3. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)
• 9.4. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)
• 9.5.Soft Tissue Allografts Market: By Region, 2020-2030, USD (Million)
  • 9.5.1.Asia Pacific
    • 9.5.1.1. China
    • 9.5.1.2. Japan
    • 9.5.1.3. India
    • 9.5.1.4. Australia
    • 9.5.1.5. South Korea
    • 9.5.1.6. Rest of Asia Pacific

10. Latin America Soft Tissue Allografts Market, 2020-2030, USD (Million)

• 10.1. Market Overview
• 10.2. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)
• 10.3. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)
• 10.4. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)
• 10.5.Soft Tissue Allografts Market: By Region, 2020-2030, USD (Million)
  • 10.5.1.Latin America
    • 10.5.1.1. Brazil
    • 10.5.1.2. Mexico
    • 10.5.1.3. Rest of Latin America

11. Middle East and Africa Soft Tissue Allografts Market, 2020-2030, USD (Million)

• 11.1. Market Overview
• 11.2. Soft Tissue Allografts Market: By Product, 2020-2030, USD (Million)
• 11.3. Soft Tissue Allografts Market: By Application, 2020-2030, USD (Million)
• 11.4. Soft Tissue Allografts Market: By End-user, 2020-2030, USD (Million)
• 11.5.Soft Tissue Allografts Market: By Region, 2020-2030, USD (Million)
  • 11.5.1.Middle East and Africa
    • 11.5.1.1. GCC
    • 11.5.1.2. Africa
    • 11.5.1.3. Rest of Middle East and Africa

12. Company Profile

• 12.1. Abbvie Inc. (Allergan)
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Conmed Corporation
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. Becton Dickinson and Company
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Smith & Nephew (Osiris Therapeutics Inc.)
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Integra LifeSciences Corporation
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Stryker Corporation
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Zimmer Biomet
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. Arthrex Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Direct Biologics
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. Others
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives